Mochida Pharmaceutical Co Ltd

FRA:MFY (Japan)   Ordinary Shares
€ 17.50 (-1.13%) Jun 6
23.97
P/B:
0.84
Market Cap:
€ 636.60M ($ 693.81M)
Enterprise V:
€ 360.68M ($ 393.09M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Mochida Pharmaceutical Co Ltd ( ) from 1990 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Mochida Pharmaceutical stock (FRA:MFY) PE ratio as of Jun 07 2024 is 23.97. More Details

Mochida Pharmaceutical Co Ltd (FRA:MFY) PE Ratio (TTM) Chart

To

Mochida Pharmaceutical Co Ltd (FRA:MFY) PE Ratio (TTM) Historical Data

Total 1254
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Mochida Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-07 21.6 2024-04-04 22.8
2024-06-06 21.6 2024-04-03 23.1
2024-06-05 21.8 2024-04-02 23.2
2024-06-04 21.8 2024-03-28 23.6
2024-06-03 21.4 2024-03-27 37.8
2024-05-31 21.3 2024-03-26 37.2
2024-05-30 21.0 2024-03-25 37.2
2024-05-29 20.7 2024-03-22 37.8
2024-05-28 20.7 2024-03-21 37.6
2024-05-27 21.0 2024-03-20 37.8
2024-05-24 21.0 2024-03-19 38.0
2024-05-23 21.0 2024-03-18 38.0
2024-05-22 21.3 2024-03-15 38.0
2024-05-21 21.4 2024-03-14 37.2
2024-05-20 21.6 2024-03-13 37.0
2024-05-17 21.7 2024-03-12 37.4
2024-05-16 21.9 2024-03-11 37.4
2024-05-15 21.8 2024-03-08 38.1
2024-05-14 22.3 2024-03-07 37.8
2024-05-13 22.7 2024-03-06 37.8
2024-05-10 23.2 2024-03-05 37.2
2024-05-09 23.2 2024-03-04 37.4
2024-05-08 22.9 2024-03-01 37.6
2024-05-07 23.3 2024-02-29 38.0
2024-05-06 23.2 2024-02-28 38.0
2024-05-03 23.4 2024-02-27 37.8
2024-05-02 23.1 2024-02-26 37.6
2024-04-30 22.9 2024-02-23 37.0
2024-04-29 22.6 2024-02-22 37.0
2024-04-26 22.6 2024-02-21 37.0
2024-04-25 22.6 2024-02-20 37.2
2024-04-24 23.1 2024-02-19 37.0
2024-04-23 23.1 2024-02-16 36.4
2024-04-22 22.9 2024-02-15 35.8
2024-04-19 22.7 2024-02-14 37.2
2024-04-18 22.8 2024-02-13 38.0
2024-04-17 22.9 2024-02-12 37.8
2024-04-16 23.1 2024-02-09 37.8
2024-04-15 23.2 2024-02-08 37.8
2024-04-12 23.2 2024-02-07 37.6
2024-04-11 22.9 2024-02-06 37.6
2024-04-10 22.9 2024-02-05 38.0
2024-04-09 23.1 2024-02-02 39.7
2024-04-08 22.9 2024-02-01 39.7
2024-04-05 23.1 2024-01-31 39.7

Mochida Pharmaceutical Co Ltd (FRA:MFY) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.